Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Japan Morning Surge-Total Organ Protection: JMS-TOP Study

Trial Profile

Japan Morning Surge-Total Organ Protection: JMS-TOP Study

Phase of Trial: Phase III

Latest Information Update: 10 Sep 2018

At a glance

  • Drugs Candesartan cilexetil (Primary)
  • Indications Hypertension
  • Focus Pharmacodynamics; Therapeutic Use
  • Acronyms J-TOP
  • Most Recent Events

    • 10 Aug 2010 Status changed from active, no longer recruiting to completed.
    • 21 Jun 2010 Results presented at the 20th European Meeting on Hypertension.
    • 16 Apr 2010 Results have been published in the Journal of Hypertension.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top